Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Cancer J. Clin.,2018
2. Lung disease: resetting the redox balance in lung fibrosis;Bray;Nat. Rev. Drug Discov.,2014
3. Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death;Catanzaro;Oncotarget,2015
4. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy;Chalela;J. Thorac. Dis.,2017
5. New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment;Chen;Int. J. Mol. Sci.,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer;Biomedicine & Pharmacotherapy;2024-04
2. Construction of a prognostic model for lung adenocarcinoma based on heat shock protein-related genes and immune analysis;Cell Stress and Chaperones;2023-11
3. Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma;Anticancer Research;2023-09-29
4. Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma;Frontiers in Pharmacology;2023-05-25
5. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma;Journal of Experimental & Clinical Cancer Research;2023-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3